Imugene doses first patient in IV arm of Phase 1 onCARlytics trial targeting solid cancers | ASX:IMU, OTC:IUGNF (*.com.au)
Not sure if already posted, the PA interview
LC sounds as optimistic as always and quite frankly when listening to her one would think why isn't this tech already in Big Pharma's hand?
Comes back to trust which IMU has lost due to promises that haven't been realised by creating relevant data so far. It becomes more and more boom or bust, no 3rd option the way it looks like.
GLTA
Imugene doses first patient in IV arm of Phase 1 onCARlytics...
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.5¢ | $1.012M | 18.02M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 590122 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 1408449 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |